A 'Laser Phase Plate' Breakthrough Allows Cryo-EM to Image the Tiniest Human Proteins

For decades, structural biologists have relied on cryo-electron microscopy (cryo-EM) to map the molecular machinery of life. The technique, which won the 2017 Nobel Prize in Chemistry, fires electrons at flash-frozen biological samples to deduce their three-dimensional shapes. Yet, despite its revolutionary impact on drug discovery, conventional cryo-EM harbors a massive blind spot: it struggles to generate enough image contrast to resolve small molecules. Researchers estimate that more than 90% of the proteins inside a human cell are simply too small to be imaged clearly using standard methods.[5][6]

That visibility gap is now closing. In a coordinated suite of publications released this week, researchers from UC Berkeley and the Chan Zuckerberg Biohub announced the successful demonstration of a "laser phase plate" (LPP). Installed inside a state-of-the-art electron microscope, the device uses a highly focused laser to shift the phase of the electron beam, dramatically boosting image contrast without destroying the high-resolution signal.[3][5]

The underlying physics borrows from a nearly century-old optical breakthrough. In the 1930s, the invention of the phase-contrast light microscope allowed biologists to see transparent cellular structures that were previously invisible, earning a Nobel Prize in 1953. Translating that concept to electron microscopes, however, proved notoriously difficult. Physical phase plates made of carbon or other materials tend to charge up, contaminate quickly, and degrade the electron beam, compromising the very atomic-level resolution scientists seek.[4][5]

The solution, first proposed more than 15 years ago by UC Berkeley physicists Holger Müller and Robert Glaeser, was to replace the physical material entirely with light. Their theoretical framework suggested that focusing a continuous-wave laser at the exact point where the electron beam passes could shift the electrons' phase via the ponderomotive effect—with nothing solid in the beam path to burn or contaminate.[3][5]

For years, the concept was dismissed by many in the field as theoretically elegant but practically impossible to build. Generating the necessary phase shift requires a laser beam roughly 100 million times brighter than the surface of the sun, all contained within the ultra-high vacuum of an electron microscope column. Furthermore, the optical cavity must remain perfectly aligned at the microscopic level while avoiding any dust particles that could absorb the intense light and instantly vaporize the mirrors.[3][5]

The new publications confirm that the engineering hurdles have been cleared. Writing in the journal Science, Müller’s team detailed the performance of a custom Thermo Scientific Krios microscope—nicknamed "Theia"—outfitted with the LPP. The entire laser apparatus fits inside a device under four inches wide, dropping seamlessly into the microscope's column so that, from the outside, the instrument looks like any other standard cryo-EM setup.[1][4]

The evidence of the LPP's efficacy is striking. The Science paper presents paired laser-on and laser-off experiments using several biological benchmarks. For aldolase, a standard benchmark enzyme, the LPP provided a clear boost in contrast. More critically, the team successfully imaged hemoglobin, a 64-kilodalton blood protein that sits at the absolute lower frontier of what conventional cryo-EM can resolve.[1][3]

With the laser engaged, the resolution of the hemoglobin structure improved by up to 44%. Features that appeared as blurry blobs in standard imaging sharpened into clearly defined atomic structures. The team also imaged apoferritin at a resolution of 1.8 angstroms, approaching the theoretical limit of the technology and proving that the laser does not trade away high-resolution detail to achieve its contrast boost.[3]

A parallel effort at CZ Biohub is already pushing the technology further. Described in a preprint and supported by theoretical work published in Nature Communications, the Biohub team has developed a dual-laser system. By crossing two perpendicular laser beams operating at half power, this next-generation design reduces optical aberrations and makes the delicate mirror components significantly less likely to burn out during sustained use.[3][7]

Despite the triumphant data, the researchers emphasize transparent uncertainty regarding the timeline for widespread adoption. The current LPP systems are bespoke prototypes operating in highly specialized physics labs. For the technology to reach the thousands of structural biology core facilities worldwide, it must be commercialized and scaled by major microscope manufacturers, a process that will require substantial industrial engineering.[3]

Furthermore, while the LPP dramatically improves the imaging of purified proteins, its ultimate promise lies in cryo-electron tomography (cryo-ET)—the practice of imaging proteins in their natural, crowded cellular environment. Conventional cryo-ET suffers from notoriously low signal-to-noise ratios. The LPP's contrast boost is expected to be a game-changer for tomography, but extensive in-situ cellular imaging with the new plate remains an active area of development.[4][5]

If successfully commercialized, the laser phase plate will fundamentally alter the landscape of drug discovery. Most modern pharmaceuticals are designed by finding a small molecule that fits perfectly into a specific pocket on a disease-causing protein. If 90% of those proteins cannot be seen clearly, they cannot be effectively targeted. By making the invisible visible, the LPP provides the foundational blueprints needed to design the next generation of targeted therapeutics.[3][5]